Page last updated: 2024-09-05

sb 203580 and Embolism, Pulmonary

sb 203580 has been researched along with Embolism, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bhavan, PS; Chung, CL; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Jayakumar, T; Sheu, JR; Wu, MP1
Chan, C; Cheng, D; Chun, C; Dan, Y; Fangyou, Y; Honglei, X; Lehe, Y; Liangxing, W; Qi, Z; Weixi, Z; Xiaoying, H; Xueding, C; Yang, W; Yuanyuan, L; Zhoucang, Z1

Other Studies

2 other study(ies) available for sb 203580 and Embolism, Pulmonary

ArticleYear
Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB.
    Molecules (Basel, Switzerland), 2022, Jan-12, Volume: 27, Issue:2

    Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Free Radical Scavengers; Free Radicals; Humans; I-kappa B Kinase; Imidazoles; Indole Alkaloids; Male; Mice, Inbred ICR; NF-kappa B; Nitriles; P-Selectin; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Protein Kinase Inhibitors; Pulmonary Embolism; Pyridines; Quinazolines; Sulfones; Thrombosis; Transcription Factor RelA

2022
Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 signaling in rats.
    Life sciences, 2012, May-22, Volume: 90, Issue:19-20

    Topics: Animals; Blotting, Western; Chemokine CCL2; Down-Regulation; Enzyme Inhibitors; Fluorescent Antibody Technique; Hypertension, Pulmonary; Imidazoles; Immunohistochemistry; Indicators and Reagents; Male; p38 Mitogen-Activated Protein Kinases; Pulmonary Embolism; Pyridines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes

2012